Kaku, K., Isaka, H., Toyoshima, J., & Sakatani, T. (2019). Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo‐controlled trial. Diabetes Obes Metab.
Čikaški stil citiranjaKaku, Kohei, Hiroyuki Isaka, Junko Toyoshima, i Taishi Sakatani. "Clinical Pharmacology Study of Ipragliflozin in Japanese Patients With Type 1 Diabetes Mellitus: A Phase 2, Randomized, Placebo‐controlled Trial." Diabetes Obes Metab 2019.
MLA način citiranjaKaku, Kohei, Hiroyuki Isaka, Junko Toyoshima, i Taishi Sakatani. "Clinical Pharmacology Study of Ipragliflozin in Japanese Patients With Type 1 Diabetes Mellitus: A Phase 2, Randomized, Placebo‐controlled Trial." Diabetes Obes Metab 2019.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.